Shattuck Labs, Inc.
VSIG8-BASED CHIMERIC PROTEINS
Last updated:
Abstract:
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.
Status:
Application
Type:
Utility
Filling date:
27 Feb 2018
Issue date:
5 Dec 2019